Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection

Stopped Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).

Conditions

• COVID-19

Interventions

• DRUG: Clazakizumab
• OTHER: Placebo

Sponsor

Columbia University

Collaborators

• [object Object]
• [object Object]